ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

28,075Medicare Part D Prescriptions Filled, Including Refills

Rank: 26 out of 682

$1.26M Total Retail Price of All Prescriptions

Rank: 53 out of 682

712 Patients Receiving at Least One Drug in Part D
55%Patients 65 Years and Older
62% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kentucky
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

36% of this provider’s 712 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

2% of this provider’s 16,124 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$45 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

39 is the average number of prescriptions (including refills) per patient, compared to an average of 24.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kentucky
HYDROCODONE-ACETAMINOPHEN 998 606 S3 1 1
LISINOPRIL 933 510 2 2
FUROSEMIDE 883 600 3 7
SIMVASTATIN 790 507 4 4
LEVOTHYROXINE SODIUM 690 456 5 3
METFORMIN HCL 687 413 6 8
GABAPENTIN 674 278 7 9
OMEPRAZOLE 572 276 8 5
IBUPROFEN 545 215 9 79
ACETAMINOPHEN-CODEINE 535 200 S3 10 126
NEXIUM 510 276 11 19
AMLODIPINE BESYLATE 487 343 12 6
METOPROLOL TARTRATE 456 300 13 10
PROAIR HFA 445 223 14 45
POTASSIUM CHLORIDE 418 262 15 14
METOPROLOL SUCCINATE 385 266 16 16
RANITIDINE HCL 372 208 17 28
ATENOLOL 367 214 18 18
CRESTOR 337 171 19 22
ZOLPIDEM TARTRATE 330 99 20 21
TRAMADOL HCL 323 131 21 26
AMOXICILLIN 317 154 22 113
GLIPIZIDE 294 207 23 61
ATORVASTATIN CALCIUM 290 219 24 11
THEOPHYLLINE ANHYDROUS 251 160 25 153
TRAZODONE HCL 251 93 25 38
CITALOPRAM HBR 248 152 27 17
SERTRALINE HCL 243 112 28 24
CLOPIDOGREL 241 170 29 25
HYDROCHLOROTHIAZIDE 216 118 30 12
NYSTATIN 215 192 31 95
LISINOPRIL-HYDROCHLOROTHIAZIDE 207 93 32 34
AZITHROMYCIN 201 93 33 39
FLUOXETINE HCL 197 39 34 60
GLIMEPIRIDE 196 160 35 43
SULFAMETHOXAZOLE-TRIMETHOPRIM 194 103 36 103
ISOSORBIDE MONONITRATE ER 179 105 37 31
ALLOPURINOL 171 119 38 32
ROPINIROLE HCL 161 120 39 71
LANSOPRAZOLE 158 95 40 85
PLAVIX 153 113 41 35
WARFARIN SODIUM 152 133 42 13
TIZANIDINE HCL 148 39 43 83
METHYLPREDNISOLONE 146 71 44 127
CYCLOBENZAPRINE HCL 142 40 R 45 65
TRICOR 139 57 46 94
CLONIDINE HCL 137 87 47 48
PROMETHAZINE HCL 137 55 R 47 54
LOSARTAN POTASSIUM 136 64 49 20
DONEPEZIL HCL 134 122 50 30
PANTOPRAZOLE SODIUM 133 84 51 29
HYDROXYZINE PAMOATE 133 39 R 51 172
CARVEDILOL 133 84 51 23
CIPROFLOXACIN HCL 132 82 54 58
ENALAPRIL MALEATE 131 84 55 91
PREDNISONE 130 82 56 40
GLIPIZIDE XL 129 74 57 181
INSULIN SYRINGE 128 92 58 75
PAROXETINE HCL 126 67 59 53
NAPROXEN 123 54 60 97
SINGULAIR 121 66 61 63
BUPROPION HCL SR 120 27 62 198
PRAVASTATIN SODIUM 120 86 62 15
DEXILANT 116 47 64 201
MELOXICAM 115 67 65 27
ALENDRONATE SODIUM 111 69 66 37
ADVAIR DISKUS 109 63 67 47
TAMSULOSIN HCL 108 63 68 33
SPIRIVA 106 57 69 49
KLOR-CON M10 105 73 70 186
LANTUS 104 89 71 55
CEPHALEXIN 97 53 72 128
MECLIZINE HCL 97 83 72 124
GLIPIZIDE ER 96 43 74 108
FAMOTIDINE 95 57 75 99
AMLODIPINE BESYLATE-BENAZEPRIL 93 58 76 77
DICLOFENAC SODIUM 92 50 77 107
DIVALPROEX SODIUM 91 13 78 84
DIOVAN 89 51 79 42
AMITRIPTYLINE HCL 88 17 R 80 50
MIRTAZAPINE 87 29 81 52
DIOVAN HCT 86 63 82 109
MONTELUKAST SODIUM 85 43 83 112
LOSARTAN-HYDROCHLOROTHIAZIDE 84 43 84 56
FLUCONAZOLE 84 45 84 154
SPIRONOLACTONE 82 60 86 64
CYMBALTA 81 31 87 51
LEVOFLOXACIN 80 60 88 70
ZETIA 79 45 89 69
LYRICA 78 29 90 78
AMOX TR-POTASSIUM CLAVULANATE 74 41 91 110
EVISTA 74 64 91 135
TERAZOSIN HCL 74 62 91 171
MEGESTROL ACETATE 74 60 R 91 165
METHOCARBAMOL 72 0 R 95 163
FLUTICASONE PROPIONATE 71 38 96 36
VENTOLIN HFA 71 27 96 101
BUSPIRONE HCL 71 23 96 102
NAMENDA 70 70 99 41
CLONAZEPAM 69 40 100 194
JANUVIA 68 39 101 62
METOCLOPRAMIDE HCL 68 31 101 111
GLYBURIDE 67 56 R 103 72
FENOFIBRATE 64 35 104 76
COMBIVENT 64 39 104 105
LIPITOR 64 48 104 92
TRIAMTERENE-HCTZ 63 49 107 57
QUINAPRIL HCL 63 43 107 138
DILTIAZEM HCL 63 51 107 217
DIGOXIN 62 48 110 46
NITROSTAT 62 27 110 161
LABETALOL HCL 61 35 112 249
NASONEX 61 48 112 199
ESCITALOPRAM OXALATE 60 22 114 73
CELEBREX 60 42 114 80
SYMBICORT 57 28 116 117
ACTOS 57 26 116 151
SUCRALFATE 55 25 118 160
PHENYTOIN SODIUM EXTENDED 55 28 118 140
CILOSTAZOL 54 32 120 183
VERAPAMIL ER 54 46 120 116
PROVENTIL HFA 52 38 122 385
METHOTREXATE 52 26 122 248
QUETIAPINE FUMARATE 52 36 122 87
CEFUROXIME 52 29 122 164
CARBIDOPA-LEVODOPA 52 51 122 121
POLYETHYLENE GLYCOL 3350 50 47 127 44
LOVAZA 50 34 127 106
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 5, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.